Phase 2 Treatment Resistant Depression trials recruiting now

All Treatment Resistant Depression trials, every phase

Other phases for Treatment Resistant Depression

Phase 2 Treatment Resistant Depression trials

• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
  NCT06524830 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 48 locations
• An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
  NCT05660642 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
  NCT07211438 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
  NCT06512220 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Mindfulness Engaged Neurostimulation for Depression (MEND II)
  NCT07512284 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
  NCT07183748 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Psilocybin for Hospitalized Patients with Treatment-resistant Depression
  NCT06378229 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Psilocybin rTMS for Treatment Resistant Depression
  NCT06132178 · Phase: Phase 2 · Ages: 22 Years to 65 Years · Sex: All (male and female) · 1 location
• Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
  NCT06518720 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
  NCT06480500 · Phase: Phase 2 · Ages: 21 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.